Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Oxo Chemie initiates phase III trial of compound for late-stage HIV infection

Oct. 21, 1998

Ribi, ATL collaborate on the development of improved allergy vaccines

Oct. 20, 1998

Certiva vaccine launched in the U.S.

Oct. 16, 1998

Orphan drug designation granted to MEDI-507 for use in AlloMune system

Oct. 16, 1998

Data safety monitoring board deems Nabi S. aureus vaccine safe in hemodialysis patients

Oct. 16, 1998

Aquila reports preliminary results of phase II trial of pneumococcal vaccine

Oct. 16, 1998

New compound reported in clinical development at Lilly

Oct. 15, 1998

Immunomodulating thalidomide analogues patented by Gruenenthal

Oct. 14, 1998

Ono's new PGE2 derivatives show binding affinity for EP2 receptors

Oct. 13, 1998

Development status updated for 3M's imiquimod analogue R-848

Oct. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...